Debbie Corning joined Advantage Healthcare Inc. in 2004, bringing with her more than 20 years of experience in the pharmaceutical industry - on both the corporate and service sides. At AHI, Debbie is responsible for managing both US and global research projects, including synthesis and analyses of information from multiple inputs for commercial assessments, benchmarking studies, and marketing plans.

Debbie has successfully completed several protem assignments in which she has handled both primary and secondary research in the US, supporting New Product Commercialization and In Line Product Marketing Strategy. She works directly with the marketing team, attending key meetings and advising on all facets of market research. She has managed complex quantitative studies that influenced product positioning and promotional strategy.

Debbie started her career in 1987 at IMS Health. Her first position in their accounting department soon led to a promotion to IMS' Global Client Services Group, where she was closely involved with IMS' core products and services, interacting with pharmaceutical market research managers on a daily basis to explain complex product concepts and support their use of IMS data. Debbie also designed, priced, and delivered ad-hoc customized reports tailored to clients' specific needs.

In 1995, Debbie moved to the industry side of the business and joined Wyeth International as a Senior Market Research Analyst. During her 2 years at Wyeth, Debbie provided international secondary research support across all key Wyeth therapeutic areas. She interacted with product managers, local country affiliates, and global pharmaceutical management to discuss and meet their information needs, utilizing a variety of secondary information sources and databases. Debbie also designed, produced, and analyzed sales and medical data reports on markets, products, therapeutic disease areas, and companies to support strategic and tactical business decisions.

After only 2 years at Wyeth, Debbie accepted a Manager position with Johnson & Johnson Pharmaceutical Group Strategic Marketing (global marketing), which provided her the opportunity to more closely manage primary research projects in the epilepsy, neuropathic pain, migraine, bipolar disorder, and obesity markets. While at J & J, Debbie interacted daily with product managers to gain a clear understanding of marketing strategy and business objectives. She then used this knowledge to design global primary research studies for J & J's CNS and Women's Health franchises. Debbie also worked closely with the Johnson & Johnson operating companies to allow a smooth implementation of projects at the local country level. Debbie conducted a broad range of strategic and tactical projects, including product positioning, trade-off analysis, product profile tests, product/brand awareness studies, detail aid testing, and package research.

After 3 years at Johnson & Johnson, Debbie accepted a position with Bristol-Myers Squibb Company, which allowed her to utilize both her primary and secondary market research skills. As Associate Director of Oncology Market Research, Debbie was responsible for effectively integrating marketing research into the Bristol-Myers Squibb product development and commercialization process for their worldwide oncology franchise. Debbie independently represented the market research function on key business teams to help guide new product clinical development and marketing strategy for the global oncology group. She established standards on the appropriate research projects and data analyses to be conducted at each stage of product development. Debbie also developed a keen interest in oncology and acquired a solid knowledge base of this disease area.

In 2002, Debbie accepted a Director position with Schering AG/Berlex Laboratories, which afforded her the opportunity to add another skill set to her armamentarium forecasting. Debbie designed and implemented forecasting policies and procedures within the oncology strategic business unit, and developed forecasts that helped guide business decisions regarding portfolio management and new product/licensing evaluations.

As part of this process, Debbie created/built the necessary tools to provide sound forecast inputs (eg, epidemiology models, competitor profiles, a minimum clinical hurdles database). She also liaised with marketing, clinical, regulatory, and production to obtain the necessary forecast parameters and assumptions.

When Debbie joined AHI in 2004, she brought with her many years of industry experience and a broad-based skill set allowing her to perform a wide range of market research functions for AHI projects. Debbie has a BBA in Accounting from Temple University and an MBA in Pharmaceutical Marketing from Saint Joseph's University. She also served for 4 years as an officer of the Pharmaceutical Business Intelligence and Research Group as Vice President of Business Research (1997-1998) and Vice President of Primary Research (1999-2000).